Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 51

Sort by

Sort Order Select

Journal Articles

Clonal evolution dissection reveals that a high MSI2 level promotes chemoresistance in T-cell acute lymphoblastic leukemia

Blood (2024) 143 (4): 320–335.

https://doi.org/10.1182/blood.2023020490

Published: 2024

Includes: Supplemental data

Journal Articles

Loncastuximab Tesirine Demonstrated Substantial Single-Agent Efficacy and Manageable Safety Profile in Heavily Pretreated Chinese Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Blood (2023) 142 (Supplement 1): 4469.

https://doi.org/10.1182/blood-2023-173645

Published: 2023

Journal Articles

Treatment of Relapsed/Refractory Hgbcl and Bukitt's Lymphoma with c-Myc Rearrangement: A Multi-Center, Open-Label, Phase 2 Study of PC-002 (SepB), a First-in-Class Deubiquitinase Inhibitor Inducing Myc Degradation

Blood (2023) 142 (Supplement 1): 1754.

https://doi.org/10.1182/blood-2023-190995

Published: 2023

Journal Articles

Pirtobrutinib, a Non-Covalent (reversible) BTK Inhibitor, in Mantle Cell Lymphoma Patients Previously Treated with a Covalent BTK Inhibitor: Results from a China Phase 2 Study

Yuqin Song, Shuhua Yi, Haiyan Yang, Ru Feng, Huiqiang Huang, Qingyuan Zhang, Yanyan Liu, Ye Guo, Huilai Zhang, Liling Zhang, Yijiao Qian, JianKun Zhu, Jun Zhu

Blood (2023) 142 (Supplement 1): 3636.

https://doi.org/10.1182/blood-2023-173287

Published: 2023

Journal Articles

A Phase Ib Open-Label Study of MRG001 in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)

Jun Zhu, Yuqin Song, Ye Guo, Keshu Zhou, Wenyu Li, Yu Yang, Qingqing Cai, Zhao Wang, Haiyan Yang

Blood (2023) 142 (Supplement 1): 3089.

https://doi.org/10.1182/blood-2023-189675

Published: 2023

Journal Articles

Gene-Edited Universal CD7 Chimeric Antigen Receptor T Cells for Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Fang Liu, Ye Guo, Wenyu Yang, Ying Wang, Xiaofan Zhu

Blood (2023) 142 (Supplement 1): 2109.

https://doi.org/10.1182/blood-2023-185754

Published: 2023

Journal Articles

Decitabine in Combination with Aclacinomycin, Cytarabine and Granulocyte Colony-Simulating Factor (CAG) Had a High Response Rate in Children with Advanced Myelodysplastic Syndrome and Acute Myeloid Leukemia with Myelodysplasia-Related Changes

Yuanyuan Ren, Yumei Chen, Shuchun Wang, Tianfeng Liu, Yang Wan, Jingliao Zhang, Wenyu Yang, Ye Guo, Xiaofan Zhu

Blood (2023) 142 (Supplement 1): 6480.

https://doi.org/10.1182/blood-2023-184620

Published: 2023

Journal Articles

A Phase Ib Study of Linperlisib Monotherapy in Patients with Relapsed or Refractory B-Cell Malignancies

Wei Liu, Yunhong Huang, Haiyan Yang, Zhiming Li, Zhen Cai, Zhen Wang, Lihong Liu, Ye Guo, Ligen Liu, Rui Huang, Xu Ye, Lugui Qiu

Blood (2023) 142 (Supplement 1): 1722.

https://doi.org/10.1182/blood-2023-177550

Published: 2023

Journal Articles

Clinical Feature and Effect of Demethylation Therapy in Pediatric Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes

Yang Wan, Ranran Zhang, Min Ruan, Jun Li, Xiaolan Li, Xiaoyan Zhang, Xiaojuan Chen, Li Zhang, Yao Zou, Yumei Chen, Ye Guo, Wenyu Yang, Xiaofan Zhu

Blood (2022) 140 (Supplement 1): 11628–11629.

https://doi.org/10.1182/blood-2022-168436

Published: 2022

Journal Articles

Clinical Characteristics and Stratified Analysis of Ph-like Acute Lymphoblastic Leukemia in Children: A Retrospective Study from China

Xiaoyan Zhang, Xiaofan Zhu, Xiaojuan Chen, Wenyu Yang, Ye Guo

Blood (2022) 140 (Supplement 1): 11584–11585.

https://doi.org/10.1182/blood-2022-166291

Published: 2022

Journal Articles

Short-Term Follow-up of Blinatumomab in Children with B-Cell Precursor Acute Lymphoblastic Leukemia：Study of a Single Center from China

Wenyu Yang, Xiaolan Li, Li-Peng Liu, Yang Wan, Tianfeng Liu, Bei-bei Zhao, Min Ruan, Benquan Qi, Xia Chen, Fang Liu, Yuanyuan Ren, Li Zhang, Yao Zou, Yumei Chen, Xiaojuan Chen, Ye Guo, Xiaofan Zhu

Blood (2022) 140 (Supplement 1): 13214–13215.

https://doi.org/10.1182/blood-2022-164642

Published: 2022

Journal Articles

Efficacy and Safety of Relmacabtagene Autoleucel in Adults with Relapsed/Refractory Follicular Lymphoma in China

Yuqin Song, Zhitao Ying, Haiyan Yang, Ye Guo, Wenyu Li, Dehui Zou, Jianqiu Wu, Alex Tian, Tony Huang, Zisong Zhou, Meilin Ma, Su Yang, Yun Qin, Jun Zhu

Blood (2022) 140 (Supplement 1): 10329–10331.

https://doi.org/10.1182/blood-2022-162985

Published: 2022

Journal Articles

Correlation Analysis of Initial Methylation Stratification and Clinical Characteristics in Juvenile Myelomonocytic Leukemia

Wenyu Yang, Chenmeng Liu, Xiaolan Li, Li-Peng Liu, Fang Liu, Yao Zou, Yumei Chen, Li Zhang, Xiaojuan Chen, Ye Guo, Xiaofan Zhu

Blood (2022) 140 (Supplement 1): 12264–12265.

https://doi.org/10.1182/blood-2022-166110

Published: 2022

Journal Articles

Preliminary Safety and Efficacy of Zanubrutinib in Combination with Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Huilai Zhang, Keshu Zhou, Ying Cheng, Liling Zhang, Haiyan Yang, Liqun Zou, Junning Cao, Huiqiang Huang, Ye Guo, Zhao Wang, Sha Huang, Zhiyu Liang, Hui Yao, Haiyi Guo, Yiqian Fang, Hongjie Zhu

Blood (2022) 140 (Supplement 1): 3750–3752.

https://doi.org/10.1182/blood-2022-155979

Published: 2022

Journal Articles

Analysis of Clinical Characteristics of Childhood Myelodysplastic Syndrome with Increased Blasts (cMDS-IB)

Wenyu Yang, Chenmeng Liu, Xiaolan Li, Yang Wan, Yao Zou, Yumei Chen, Li Zhang, Xiaojuan Chen, Ye Guo, Xiaofan Zhu

Blood (2022) 140 (Supplement 1): 11475–11476.

https://doi.org/10.1182/blood-2022-164660

Published: 2022

Journal Articles

Decoding Clonal Evolution in Relapsed T Cell Acute Lymphoblastic Leukemia at Single Cell Resolution

Jingliao Zhang, Yongjuan Duan, Yanxia Chang, Yue Wang, Chao Liu, Ye Guo, Xiaojuan Chen, Li Zhang, Xiaofan Zhu, Yingchi Zhang

Blood (2021) 138 (Supplement 1): 3482.

https://doi.org/10.1182/blood-2021-153299

Published: 2021

Journal Articles

Primary Clinical Response of Relmacabtagene Autoleucel in Adults with Relapsed/Refractory Follicular Lymphoma (r/r FL) in China

Yuqin Song, Zhitao Ying, Haiyan Yang, Ye Guo, Wenyu Li, Dehui Zou, Jianqiu Wu, Su Yang, Pian Zhang, Meilin Ma, Zisong Zhou, Hongxia Zheng, Jun Zhu

Blood (2021) 138 (Supplement 1): 2434.

https://doi.org/10.1182/blood-2021-150085

Published: 2021

Journal Articles

A Dose Escalation Phase Ia Study of Anti-CD20 Antibody Drug Conjugate, MRG001 in Relapsed/Refractory Advanced Non-Hodgkin Lymphom

Yuqin Song, Ye Guo, Zhao Wang, Meng Wu, Wei Peng, Lei Sun, Jinghui Sun, Maggie Li, Jun Zhu

Blood (2021) 138 (Supplement 1): 2490.

https://doi.org/10.1182/blood-2021-144829

Published: 2021

Journal Articles

Relmacabtagene Autoleucel CD19 CART Therapy for Adults with Heavily-Pretreated Relapsed/Refractory Large B-Cell Lymphoma in China

Yuqin Song, Zhitao Ying, Haiyan Yang, Ye Guo, Wenyu Li, Dehui Zou, Daobin Zhou, Zhao Wang, Mingzhi Zhang, Jianqiu Wu, Hui Liu, Pian Zhang, Su Yang, Zisong Zhou, Hongxia Zheng, Jun Zhu

Blood (2021) 138 (Supplement 1): 3557.

https://doi.org/10.1182/blood-2021-148358

Published: 2021

Journal Articles

A Phase1b Clinical Study of the Oral PI3Kδ Inhibitor, Linperlisib, in Patients with B-Cell Lymphomas

Lugui Qiu, Zhiming Li, Yunhong Huang, Ligen Liu, Lihong Liu, Ye Guo, Lan Deng, Haiyan Yang, Zhen CAI, Xu Ye, Zhen Wang, Hanying Bao, Zusheng Xu, Binghua Zheng

Blood (2021) 138 (Supplement 1): 3576.

https://doi.org/10.1182/blood-2021-148276

Published: 2021

NARROW

Clonal evolution dissection reveals that a high MSI2 level promotes chemoresistance in T-cell acute lymphoblastic leukemia

Loncastuximab Tesirine Demonstrated Substantial Single-Agent Efficacy and Manageable Safety Profile in Heavily Pretreated Chinese Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Treatment of Relapsed/Refractory Hgbcl and Bukitt's Lymphoma with c-Myc Rearrangement: A Multi-Center, Open-Label, Phase 2 Study of PC-002 (SepB), a First-in-Class Deubiquitinase Inhibitor Inducing Myc Degradation

Pirtobrutinib, a Non-Covalent (reversible) BTK Inhibitor, in Mantle Cell Lymphoma Patients Previously Treated with a Covalent BTK Inhibitor: Results from a China Phase 2 Study

A Phase Ib Open-Label Study of MRG001 in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)

Gene-Edited Universal CD7 Chimeric Antigen Receptor T Cells for Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Decitabine in Combination with Aclacinomycin, Cytarabine and Granulocyte Colony-Simulating Factor (CAG) Had a High Response Rate in Children with Advanced Myelodysplastic Syndrome and Acute Myeloid Leukemia with Myelodysplasia-Related Changes

A Phase Ib Study of Linperlisib Monotherapy in Patients with Relapsed or Refractory B-Cell Malignancies

Clinical Feature and Effect of Demethylation Therapy in Pediatric Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Changes

Clinical Characteristics and Stratified Analysis of Ph-like Acute Lymphoblastic Leukemia in Children: A Retrospective Study from China

Short-Term Follow-up of Blinatumomab in Children with B-Cell Precursor Acute Lymphoblastic Leukemia：Study of a Single Center from China

Efficacy and Safety of Relmacabtagene Autoleucel in Adults with Relapsed/Refractory Follicular Lymphoma in China

Correlation Analysis of Initial Methylation Stratification and Clinical Characteristics in Juvenile Myelomonocytic Leukemia

Preliminary Safety and Efficacy of Zanubrutinib in Combination with Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Analysis of Clinical Characteristics of Childhood Myelodysplastic Syndrome with Increased Blasts (cMDS-IB)

Decoding Clonal Evolution in Relapsed T Cell Acute Lymphoblastic Leukemia at Single Cell Resolution

Primary Clinical Response of Relmacabtagene Autoleucel in Adults with Relapsed/Refractory Follicular Lymphoma (r/r FL) in China

A Dose Escalation Phase Ia Study of Anti-CD20 Antibody Drug Conjugate, MRG001 in Relapsed/Refractory Advanced Non-Hodgkin Lymphom

Relmacabtagene Autoleucel CD19 CART Therapy for Adults with Heavily-Pretreated Relapsed/Refractory Large B-Cell Lymphoma in China

A Phase1b Clinical Study of the Oral PI3Kδ Inhibitor, Linperlisib, in Patients with B-Cell Lymphomas

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only